SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 3.470B
March 31, 2026 3.512B
December 31, 2025 3.426B
September 30, 2025 3.408B
June 30, 2025 3.414B
March 31, 2025 3.347B
December 31, 2024 3.399B
September 30, 2024 3.412B
June 30, 2024 3.444B
March 31, 2024 3.458B
December 31, 2023 3.455B
September 30, 2023 3.520B
June 30, 2023 3.653B
March 31, 2023 3.843B
December 31, 2022 3.981B
September 30, 2022 3.948B
June 30, 2022 3.813B
March 31, 2022 3.780B
December 31, 2021 3.660B
September 30, 2021 3.798B
June 30, 2021 3.774B
March 31, 2021 3.587B
December 31, 2020 3.671B
September 30, 2020 3.495B
June 30, 2020 3.462B
Date Value
March 31, 2020 3.551B
December 31, 2019 3.422B
September 30, 2019 3.351B
June 30, 2019 3.409B
March 31, 2019 3.360B
December 31, 2018 3.398B
September 30, 2018 3.689B
June 30, 2018 3.774B
March 31, 2018 3.912B
December 31, 2017 4.045B
September 30, 2017 3.772B
June 30, 2017 3.708B
March 31, 2017 3.459B
December 31, 2016 3.234B
September 30, 2016 3.151B
June 30, 2016 3.010B
March 31, 2016 2.994B
December 31, 2015 2.881B
September 30, 2015 2.782B
June 30, 2015 2.699B
March 31, 2015 2.613B
December 31, 2014 2.601B
September 30, 2014 2.572B
June 30, 2014 2.505B
March 31, 2014 2.465B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
DaVita, Inc. 1.732B
Rhön-Klinikum AG 213.52M
FamiCord AG 65.83M
Quest Diagnostics, Inc. 2.038B
Acadia Healthcare Co., Inc. 208.76M